This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
T. L. Brink , J. A. Yesavage , O. Lum , P. Heersema , M. B. Adey and T. L. Rose (1982). Screening tests for geriatric depression. Clinical Gerontologist, 1, 37–44.
M. C. Corballis (2009). The evolution and genetics of cerebral asymmetry. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 364, 867–879.
R. M. Corbo and R. Scacchi (1999). Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Annals of Human Genetics, 63, 301–310.
C. L. Craig (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35, 1381–1395.
C. P. Ferri (2005). Global prevalence of dementia: a Delphi consensus study. Lancet, 366, 2112–2117.
M. F. Folstein , S. E. Folstein and P. R. McHugh (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
L. Glodzik-Sobanska (2007). Subjective memory complaints: presence, severity and future outcome in normal older subjects. Dementia and Geriatric Cognitive Disorders, 24, 177–184.
A. Hodge , A. J. Patterson , W. J. Brown , P. Ireland and G. Giles (2000). The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Australian and New Zealand Journal of Public Health, 24, 576–583.
C. Jonker , M. I. Geerlings and B. Schmand (2000). Are memory complaints predictive for dementia? A review of clinical and population-based studies. International Journal of Geriatric Psychiatry, 15, 983–991.
B. C. Jost and G. T. Grossberg (1996). The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. Journal of the American Geriatrics Society, 44, 1078–1081.
R. J. Kryscio , F. A. Schmitt , J. C. Salazar , M. S. Mendiondo and W. R. Markesbery (2006). Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology, 66, 828–832.
S. Larrieu (2002). Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 59, 1594–1599.
N. T. Lautenschlager (2008). Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA, 300, 1027–1037.
C. G. Lyketsos and J. Olin (2002). Depression in Alzheimer's disease: overview and treatment. Biological Psychiatry, 52, 243–252.
R. N. Martins (1995). ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Neuroreport, 6, 1513–1516.
G. McKhann , D. Drachman , M. Folstein , R. Katzman , D. Price and E. M. Stadlan (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.
M. S. Mega , J. L. Cummings , T. Fiorello and J. Gornbein (1996). The spectrum of behavioral changes in Alzheimer's disease. Neurology, 46, 130–135.
J. C. Morris (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.
R. C. Petersen , G. E. Smith , S. C. Waring , R. J. Ivnik , E. G. Tangalos and E. Kokmen (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303–308.
K. E. Pike (2007). Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain, 130, 2837–2844.
B. Reisberg and S. Gauthier (2008). Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics, 20, 1–16.
R. Rozzini , M. P. Gozzoli , A. Indelicato , F. Lonati and M. Trabucchi (2008). Patterns of antidepressants prescriptions in a large Italian old population. International Journal of Geriatric Psychiatry, 23, 872–873.
C. C. Rowe (2007). Imaging beta-amyloid burden in aging and dementia. Neurology, 68, 1718–1725.
J. Saxton (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clinical Neuropsychology, 14, 526–534.
R. P. Snaith and A. S. Zigmond (1986). The hospital anxiety and depression scale. British Medical Journal, 292, 344.
V. Solfrizzi (2004). Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology, 63, 1882–1891.
D. Wechsler (1945). A standardised memory scale for clinical use. Journal of Psychology, 19, 87–95.
B. Winblad (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240–246.
J. A. Yesavage (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 37–49.
A. S. Zigmond and R. P. Snaith (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.